Ben, I agree that the progress here is slow and the communication could be better. No disagreement from me there. The PD1-Vaxx 1a trial completed enrolment in Jan 2022 and the combo trial started in June 2023 - a full 18 months between the two.
That said, the 1b trial spans 6 sites across 2 countries and involves a supply agreement with Roche. There are over 300 active trials with Atezolizumab alone. So, I don't think the amount of effort involved in that undertaking can be underestimated.
On the supposition piece, none of the communication gets better unless we shareholders start asking more questions, more often. I've started doing that given I have significantly increased my holding at these lower prices (where I first started i might add) and I want to be better informed.
GLTAH
- Forums
- ASX - By Stock
- IMU
- Ann: Imugene PD1-Vaxx Update
Ann: Imugene PD1-Vaxx Update, page-112
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
-0.001(2.04%) |
Mkt cap ! $357.0M |
Open | High | Low | Value | Volume |
4.9¢ | 4.9¢ | 4.8¢ | $279.2K | 5.733M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
94 | 12992150 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 1795056 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
93 | 12942150 | 0.048 |
44 | 4009024 | 0.047 |
33 | 3946479 | 0.046 |
48 | 4998765 | 0.045 |
9 | 899955 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 1795056 | 6 |
0.050 | 1199729 | 8 |
0.051 | 1430603 | 8 |
0.052 | 1994270 | 12 |
0.053 | 2727411 | 21 |
Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |